The new Coronavius, the Albanian physician in England: It won't bring increased mortality

The vaccine process is in its early stages, the vaccine has taken place in about 50 hospitals in England and has begun in Scotland. Today is the first day that the vaccine will take place in medical centers. This has increased optimism in the population, people are very interested in showing up for the vaccine. Interest has been enormous, we had to change the phone answers at my center, ask patients not to call to receive vaccine meetings, but they will be contacted and presented at the vaccine center to get the” vaccine, he said.

The doctor further explained that until now the vaccine has proved effective and that it has shown problems only in two patients who are allergic to antibiotics.

There were no worries, on the first day there were two cases that were people who had allergies from vaccines. But, other cases, people haven't had any kind of problem”, said Mr. Balliu.

The doctor also talked about the mutation in the coronary. He stressed that in this case there is no thought to be an increase in mortality or that this new virus will challenge vaccines.

And this is true, this has been given to show that England's observation system is very powerful. We don't only see if one person has a virus, but also the virus type. This new mutation is thought to have been from the second part of October, we have as many as 1,000 cases of this virus. The virus always changes to fit into human cells. These bring no advantage to the virus. At times, these changes in the virus make it more infectious, and there are times that can make the virus an advantage of how to avoid vaccines because of the treatments we are taking. In the case of this virus, it is not thought that there is an increase in disease and mortality from this virus, nor is it thought to have a protection against future vaccines being used or released.”, the doctor said.